Company Ziccum AB

ZICC

SE0011415595

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sector Biopharmaceuticals

Market Closed - Nasdaq Stockholm Other stock markets 11:00:09 2024-04-29 am EDT			5-day change	1st Jan Change
6.04 ^SEK	-0.98%		-4.73%	-21.15%

Mar. 14	Ziccum AB Inhalable mRNA/LNP Project Confirms Excellent Properties Obtained by LaminarPace	CI
Mar. 01	Ziccum AB and project partner Zurich institute of Applied Sciences Updates LaminarPace Simulation Project Progress and Findings	CI

Ziccum AB is a Sweden-based pharmaceutical company that is mainly engaged in developing vaccines. Ziccum develops new thermostable versions of vaccines and biologics for licensing to vaccine suppliers, developers, manufacturers and CDMOs in the global pharmaceutical industry. Ziccum's patented drying technology, LaminarPace, is unique. It can dry-formulate temperature-sensitive vaccine materials at room temperature with high yield and low waste. These robust, thermostable dry powders can be stored and transported worldwide without the need for a cold chain or freezing. The company conducts its business by entering into strategic collaborations with major pharmaceutical companies and offering licenses to the Company's patented technology.

Number of employees: 8

SEK in Million	2022	Weight	2023	Weight	Delta
Patented Spray Drying Technology 100.0 %	0	nan %	4	100.0 %	-

SEK in Million	2022	Weight	2023	Weight	Delta
Sweden 100.0 %	0	nan %	4	100.0 %	-

Managers	Title	Age	Since
Ann Gidner CEO	Chief Executive Officer	58	22-05-08
Johny Humaloja DFI	Director of Finance/CFO	58	23-06-14
Karl Fredrik Sjövall CHM	Chairman	44	17-04-04
Xavier Turon COO	Chief Operating Officer	-	23-09-04
Fabrice Rose CTO	Chief Tech/Sci/R&D Officer	49	22-07-31

Members of the board	Title	Age	Since
Karl Fredrik Sjövall CHM	Chairman	44	17-04-04
Per Magnus Gerde BRD	Director/Board Member	-	-
Andreas Rohman Pettersson BRD	Director/Board Member	44	21-04-26
Mikaela Bruhammar BRD	Director/Board Member	48	19-04-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	15,340,157	11,592,565 ( 75.57 %)	0	75.57 %

Ziccum AB

Scheelevägen 22

223 63, Lund

http://www.ziccum.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
ZICCUM AB	-21.15%	8.5M
CSL LIMITED	-3.54%	87.17B
SAMSUNG BIOLOGICS CO.,LTD.	+1.97%	40.1B
UCB	+56.59%	25.12B
BIOMARIN PHARMACEUTICAL INC.	-14.82%	15.59B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-8.82%	12B
INCYTE CORPORATION	-16.29%	11.8B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-41.58%	11.8B
SWEDISH ORPHAN BIOVITRUM AB	+6.14%	8.81B
INNOVENT BIOLOGICS, INC.	-9.71%	8.24B

Biopharmaceuticals